Rhoda Au1, Ryan J Piers2, Sherral Devine2. 1. Department of Anatomy and Neurobiology, Boston University School of Medicine. 2. Department of Neurology, Boston University School of Medicine.
Abstract
OBJECTIVE: This article elucidates how the Boston process approach (BPA) can amplify the role of neuropsychology in the study of preclinical and clinical dementia, particularly Alzheimer's disease (AD), and how advancements in technology expand BPA capacity objectively and exponentially. METHOD: The BPA is based on a conceptualization of cognition as being comprised of multiple processes, the nature of which could not possibly be captured by a single score on a test or battery of tests. Identification of these processes is only possible with careful observation of an individual during the entire testing process to determine how, when, and why a person fails, which helps to reveal the integrity of the cognitive processes underlying the behavior. RESULTS: BPA use within the Framingham Heart Study is described, including how digital technology has been incorporated to enhance the sensitivity of BPA to detect insidious onset changes even earlier than had been previously possible. The digital technology movement will dramatically alter the means by which cognitive function is assessed going forward. CONCLUSIONS: Technological advances will catalyze groundbreaking discoveries for effective treatments of neurodegenerative cognitive disorders, such as AD, and inform novel strategies for dementia prevention and sustained lifelong cognitive health. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
OBJECTIVE: This article elucidates how the Boston process approach (BPA) can amplify the role of neuropsychology in the study of preclinical and clinical dementia, particularly Alzheimer's disease (AD), and how advancements in technology expand BPA capacity objectively and exponentially. METHOD: The BPA is based on a conceptualization of cognition as being comprised of multiple processes, the nature of which could not possibly be captured by a single score on a test or battery of tests. Identification of these processes is only possible with careful observation of an individual during the entire testing process to determine how, when, and why a person fails, which helps to reveal the integrity of the cognitive processes underlying the behavior. RESULTS:BPA use within the Framingham Heart Study is described, including how digital technology has been incorporated to enhance the sensitivity of BPA to detect insidious onset changes even earlier than had been previously possible. The digital technology movement will dramatically alter the means by which cognitive function is assessed going forward. CONCLUSIONS: Technological advances will catalyze groundbreaking discoveries for effective treatments of neurodegenerative cognitive disorders, such as AD, and inform novel strategies for dementia prevention and sustained lifelong cognitive health. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Authors: Kathryn A Ellis; Yen Ying Lim; Karra Harrington; David Ames; Ashley I Bush; David Darby; Ralph N Martins; Colin L Masters; Christopher C Rowe; Greg Savage; Cassandra Szoeke; Victor L Villemagne; Paul Maruff Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Beth E Snitz; Lisa A Weissfeld; Ann D Cohen; Oscar L Lopez; Robert D Nebes; Howard J Aizenstein; Eric McDade; Julie C Price; Chester A Mathis; William E Klunk Journal: Am J Geriatr Psychiatry Date: 2015-02-11 Impact factor: 4.105
Authors: D L Bachman; P A Wolf; R T Linn; J E Knoefel; J L Cobb; A J Belanger; L R White; R B D'Agostino Journal: Neurology Date: 1993-03 Impact factor: 9.910
Authors: D L Bachman; P A Wolf; R Linn; J E Knoefel; J Cobb; A Belanger; R B D'Agostino; L R White Journal: Neurology Date: 1992-01 Impact factor: 9.910
Authors: Eric M Reiman; Yakeel T Quiroz; Adam S Fleisher; Kewei Chen; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Anne M Fagan; Aarti R Shah; Sergio Alvarez; Andrés Arbelaez; Margarita Giraldo; Natalia Acosta-Baena; Reisa A Sperling; Brad Dickerson; Chantal E Stern; Victoria Tirado; Claudia Munoz; Rebecca A Reiman; Matthew J Huentelman; Gene E Alexander; Jessica B S Langbaum; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera Journal: Lancet Neurol Date: 2012-11-06 Impact factor: 44.182
Authors: Stephanie Reeves; Victoria Williams; Francisco M Costela; Rocco Palumbo; Olivia Umoren; Mikaila M Christopher; Deborah Blacker; Russell L Woods Journal: Neuropsychology Date: 2020-01-30 Impact factor: 3.295